Assignee
DOMANTIS LTD
GB·12 granted patents·35 pending applications·777 citations·filing 1998–2018
Top patents by PatentIndex Score
47 records- 0197US6846634B1Method to screen phage display libraries with different ligandsDOMANTIS LTD·Filed 2000·Granted Jan 25, 2005·174 cites·19 claims
- 0297US6696245B2Methods for selecting functional polypeptidesDOMANTIS LTD·Filed 1998·Granted Feb 24, 2004·503 cites·21 claims
- 0396US7563443B2Monovalent anti-CD40L antibody polypeptides and compositions thereofDOMANTIS LTD·Filed 2005·Granted Jul 21, 2009·42 cites·40 claims
- 0492US7696320B2Ligands that have binding specificity for VEGF and/or EGFR and methods of use thereforDOMANTIS LTD·Filed 2006·Granted Apr 13, 2010·25 cites·65 claims
- 0586US7442159B1Selection systemDOMANTIS LTD·Filed 2000·Granted Oct 28, 2008·20 cites·21 claims
- 0685US7927596B2Methods of antagonizing binding of CD40 to CD40L with CD40L-specific monovalent polypeptidesDOMANTIS LTD·Filed 2009·Granted Apr 19, 2011·5 cites·73 claims
- 0784US7829096B2CD40L-specific monovalent polypeptidesDOMANTIS LTD·Filed 2009·Granted Nov 9, 2010·4 cites·99 claims
- 0877US8357780B2Polypeptides, antibody variable domains and antagonists methods forDOMANTIS LTD·Filed 2008·Granted Jan 22, 2013·2 cites·12 claims
- 0975US9629909B2Methods for targeting pulmonary diseases with agents that bind a target in pulmonary tissueDOMANTIS LTD·Filed 2013·Granted Apr 25, 2017·2 cites·70 claims
- 1064US2007111282A1Method to screen phage display libraries with different ligandsDOMANTIS LTD·Filed 2006·Application pending·0 cites
- 1162US2015087813A1LigandDOMANTIS LTD·Filed 2014·Application pending·0 cites
- 1260US9562090B2Polypeptides, antibody variable domains and antagonistsDOMANTIS LTD·Filed 2013·Granted Feb 7, 2017·0 cites·48 claims
- 1360US2010234570A1LigandDOMANTIS LTD·Filed 2006·Application pending·0 cites
- 1460US2005202512A1Method to screen phage display libraries with different ligandsDOMANTIS LTD·Filed 2005·Application pending·0 cites
- 1560US2007093651A1LigandDOMANTIS LTD·Filed 2006·Application pending·0 cites
- 1659US10072089B2Polypeptides, antibody variable domains and antagonistsDOMANTIS LTD·Filed 2016·Granted Sep 11, 2018·0 cites·20 claims
- 1758US2005271663A1Compositions and methods for treating inflammatory disordersDOMANTIS LTD·Filed 2004·Application pending·0 cites
- 1858US2006106203A1LigandDOMANTIS LTD·Filed 2004·Application pending·0 cites
- 1958US2006063921A1LigandDOMANTIS LTD·Filed 2005·Application pending·0 cites
- 2058US2004038291A2Method to screen phage display libraries with different ligandsDOMANTIS LTD·Filed 2001·Application pending·0 cites
- 2158US2019040148A1Polypeptides, antibody variable domains & antagonistsDOMANTIS LTD·Filed 2018·Application pending·0 cites
- 2256US2009258012A1Compositions and methods for treating inflammatory disordersDOMANTIS LTD·Filed 2009·Application pending·0 cites
- 2356US2009081233A1Ligands that have binding specificity for VEGF and/or EGFR and methods of use thereforDOMANTIS LTD·Filed 2008·Application pending·0 cites
- 2455US2006263768A1Matrix screening methodDOMANTIS LTD·Filed 2006·Application pending·0 cites
- 2554US2011097339A1Compositions monovalent for CD28 binding and methods of useDOMANTIS LTD·Filed 2009·Application pending·0 cites
- 2654US2017210814A1Methods for targeting pulmonary diseases with agents that bind a target in pulmonary tissueDOMANTIS LTD·Filed 2017·Application pending·0 cites
- 2754US2011172400A1Compositions monovalent for cd40l binding and methods of useDOMANTIS LTD·Filed 2010·Application pending·0 cites
- 2853US2010056439A1Ligands that have binding specificity for egfr and/or vegf and methods of use thereforDOMANTIS LTD·Filed 2006·Application pending·0 cites
- 2953US2007065440A1Antibody compositions and methodsDOMANTIS LTD·Filed 2006·Application pending·0 cites
- 3053US2011159003A1Ligands That Bind Il-4 and/or Il-13DOMANTIS LTD·Filed 2007·Application pending·0 cites
- 3150US2008008713A1Single domain antibodies against tnfr1 and methods of use thereforDOMANTIS LTD·Filed 2005·Application pending·0 cites
- 3250US2006257406A1LigandDOMANTIS LTD·Filed 2005·Application pending·0 cites
- 3349US2004009507A1Concatenated nucleic acid sequenceDOMANTIS LTD·Filed 2003·Application pending·0 cites
- 3448US2008241166A1Ligands that bind a receptorDOMANTIS LTD·Filed 2008·Application pending·0 cites
- 3547US2017145080A1LigandDOMANTIS LTD·Filed 2015·Application pending·0 cites
- 3647US2006002935A1Tumor Necrosis Factor Receptor 1 antagonists and methods of use thereforDOMANTIS LTD·Filed 2004·Application pending·0 cites
- 3747US2013041136A1Ligands that have binding specificity for egfr and/or vegf and methods of use thereforDOMANTIS LTD·Filed 2012·Application pending·0 cites
- 3845US2008038735A1Tus DNA binding domainsDOMANTIS LTD·Filed 2007·Application pending·0 cites
- 3943US2010021473A1Bispecific Ligands With Binding Specificity to Cell Surface Targets and Methods of Use ThereforDOMANTIS LTD·Filed 2006·Application pending·0 cites
- 4043US2009111745A1Plad Domain Peptides With Increased Serum Half Life Due To Conjugation To Domain AntibodiesDOMANTIS LTD·Filed 2005·Application pending·0 cites
- 4143US2006280734A1RetargetingDOMANTIS LTD·Filed 2005·Application pending·0 cites
- 4242US2006083747A1Fc fusionDOMANTIS LTD·Filed 2005·Application pending·0 cites
- 4341US2006286066A1Pegylated immunoglobulin variable region polypeptidesDOMANTIS LTD·Filed 2005·Application pending·0 cites
- 4440US2003039958A1Direct screening methodDOMANTIS LTD·Filed 2002·Application pending·0 cites
- 4540US2013216538A1Compositions and Methods for Treating Inflammatory DisordersDOMANTIS LTD·Filed 2013·Application pending·0 cites
- 4638US2006073141A1Compositions and methods for treating inflammatory disordersDOMANTIS LTD·Filed 2005·Application pending·0 cites
- 4735US7846721B2GAS1 universal leaderDOMANTIS LTD·Filed 2006·Granted Dec 7, 2010·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when DOMANTIS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →